nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Paresis—Temozolomide—melanoma	0.0232	0.0238	CcSEcCtD
Gadodiamide—Rigors—Vemurafenib—melanoma	0.0203	0.0208	CcSEcCtD
Gadodiamide—Personality disorder—Carmustine—melanoma	0.0202	0.0208	CcSEcCtD
Gadodiamide—Disorder sight—Temozolomide—melanoma	0.0177	0.0182	CcSEcCtD
Gadodiamide—Encephalopathy—Carmustine—melanoma	0.0136	0.014	CcSEcCtD
Gadodiamide—Gadobenate Dimeglumine—ALB—melanoma	0.0136	0.5	CrCbGaD
Gadodiamide—Gadofosveset trisodium—ALB—melanoma	0.0136	0.5	CrCbGaD
Gadodiamide—Lung disorder—Temozolomide—melanoma	0.0119	0.0123	CcSEcCtD
Gadodiamide—Extravasation—Bleomycin—melanoma	0.0115	0.0118	CcSEcCtD
Gadodiamide—Injection site pain—Carmustine—melanoma	0.0107	0.011	CcSEcCtD
Gadodiamide—Extravasation—Dactinomycin—melanoma	0.0107	0.011	CcSEcCtD
Gadodiamide—Rigors—Temozolomide—melanoma	0.0104	0.0106	CcSEcCtD
Gadodiamide—Extravasation—Carmustine—melanoma	0.01	0.0103	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Vemurafenib—melanoma	0.00907	0.00932	CcSEcCtD
Gadodiamide—Hepatic enzyme increased—Temozolomide—melanoma	0.00893	0.00918	CcSEcCtD
Gadodiamide—Coordination abnormal—Carmustine—melanoma	0.0089	0.00915	CcSEcCtD
Gadodiamide—Injection site reaction—Carmustine—melanoma	0.00869	0.00894	CcSEcCtD
Gadodiamide—Coordination abnormal—Temozolomide—melanoma	0.00861	0.00885	CcSEcCtD
Gadodiamide—Phlebitis—Bleomycin—melanoma	0.00844	0.00868	CcSEcCtD
Gadodiamide—Coma—Carmustine—melanoma	0.00799	0.00821	CcSEcCtD
Gadodiamide—Phlebitis—Dactinomycin—melanoma	0.00787	0.00809	CcSEcCtD
Gadodiamide—Abnormal vision—Carmustine—melanoma	0.00763	0.00784	CcSEcCtD
Gadodiamide—Chills—Vemurafenib—melanoma	0.00745	0.00766	CcSEcCtD
Gadodiamide—Abnormal vision—Temozolomide—melanoma	0.00737	0.00758	CcSEcCtD
Gadodiamide—Phlebitis—Carmustine—melanoma	0.00737	0.00757	CcSEcCtD
Gadodiamide—Rash erythematous—Docetaxel—melanoma	0.00734	0.00754	CcSEcCtD
Gadodiamide—Dysgeusia—Vemurafenib—melanoma	0.00708	0.00728	CcSEcCtD
Gadodiamide—Myocardial ischaemia—Docetaxel—melanoma	0.00699	0.00719	CcSEcCtD
Gadodiamide—Ageusia—Docetaxel—melanoma	0.00694	0.00713	CcSEcCtD
Gadodiamide—Rigors—Docetaxel—melanoma	0.00688	0.00708	CcSEcCtD
Gadodiamide—Hot flush—Temozolomide—melanoma	0.00656	0.00674	CcSEcCtD
Gadodiamide—Menopausal symptoms—Temozolomide—melanoma	0.0065	0.00668	CcSEcCtD
Gadodiamide—Extravasation—Docetaxel—melanoma	0.00644	0.00662	CcSEcCtD
Gadodiamide—Hyponatraemia—Carmustine—melanoma	0.00637	0.00655	CcSEcCtD
Gadodiamide—Bronchospasm—Bleomycin—melanoma	0.00618	0.00635	CcSEcCtD
Gadodiamide—Arthralgia—Vemurafenib—melanoma	0.00615	0.00633	CcSEcCtD
Gadodiamide—Myalgia—Vemurafenib—melanoma	0.00615	0.00633	CcSEcCtD
Gadodiamide—Ataxia—Carmustine—melanoma	0.00597	0.00613	CcSEcCtD
Gadodiamide—Anaphylactic shock—Vemurafenib—melanoma	0.0059	0.00606	CcSEcCtD
Gadodiamide—Infection—Vemurafenib—melanoma	0.00586	0.00602	CcSEcCtD
Gadodiamide—Nervous system disorder—Vemurafenib—melanoma	0.00579	0.00595	CcSEcCtD
Gadodiamide—Ataxia—Temozolomide—melanoma	0.00577	0.00593	CcSEcCtD
Gadodiamide—Injection site reaction—Docetaxel—melanoma	0.00559	0.00574	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Bleomycin—melanoma	0.00552	0.00568	CcSEcCtD
Gadodiamide—Hypotension—Vemurafenib—melanoma	0.00551	0.00567	CcSEcCtD
Gadodiamide—Myocardial infarction—Bleomycin—melanoma	0.00549	0.00565	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00537	0.00552	CcSEcCtD
Gadodiamide—Sweating increased—Temozolomide—melanoma	0.00516	0.00531	CcSEcCtD
Gadodiamide—Fatigue—Vemurafenib—melanoma	0.00509	0.00523	CcSEcCtD
Gadodiamide—Lightheadedness—Docetaxel—melanoma	0.00503	0.00517	CcSEcCtD
Gadodiamide—Renal failure—Carmustine—melanoma	0.00481	0.00494	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Carmustine—melanoma	0.00479	0.00493	CcSEcCtD
Gadodiamide—Phlebitis—Docetaxel—melanoma	0.00473	0.00487	CcSEcCtD
Gadodiamide—Flushing—Bleomycin—melanoma	0.00467	0.0048	CcSEcCtD
Gadodiamide—Body temperature increased—Vemurafenib—melanoma	0.00466	0.00479	CcSEcCtD
Gadodiamide—Pharyngitis—Dactinomycin—melanoma	0.00466	0.00479	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Temozolomide—melanoma	0.00463	0.00476	CcSEcCtD
Gadodiamide—Chills—Bleomycin—melanoma	0.00451	0.00464	CcSEcCtD
Gadodiamide—Hallucination—Carmustine—melanoma	0.00437	0.00449	CcSEcCtD
Gadodiamide—Hot flush—Docetaxel—melanoma	0.00436	0.00448	CcSEcCtD
Gadodiamide—Flushing—Dactinomycin—melanoma	0.00435	0.00448	CcSEcCtD
Gadodiamide—Hypersensitivity—Vemurafenib—melanoma	0.00435	0.00447	CcSEcCtD
Gadodiamide—Menopausal symptoms—Docetaxel—melanoma	0.00432	0.00444	CcSEcCtD
Gadodiamide—Visual disturbance—Docetaxel—melanoma	0.0043	0.00442	CcSEcCtD
Gadodiamide—Renal impairment—Docetaxel—melanoma	0.00429	0.00441	CcSEcCtD
Gadodiamide—Asthenia—Vemurafenib—melanoma	0.00423	0.00435	CcSEcCtD
Gadodiamide—Visual impairment—Carmustine—melanoma	0.00423	0.00435	CcSEcCtD
Gadodiamide—Hallucination—Temozolomide—melanoma	0.00422	0.00434	CcSEcCtD
Gadodiamide—Pharyngitis—Temozolomide—melanoma	0.00421	0.00433	CcSEcCtD
Gadodiamide—Chills—Dactinomycin—melanoma	0.00421	0.00433	CcSEcCtD
Gadodiamide—Urinary tract disorder—Temozolomide—melanoma	0.00419	0.00431	CcSEcCtD
Gadodiamide—Cardiac failure—Docetaxel—melanoma	0.00418	0.0043	CcSEcCtD
Gadodiamide—Pruritus—Vemurafenib—melanoma	0.00417	0.00429	CcSEcCtD
Gadodiamide—Urethral disorder—Temozolomide—melanoma	0.00416	0.00428	CcSEcCtD
Gadodiamide—Hyponatraemia—Docetaxel—melanoma	0.0041	0.00421	CcSEcCtD
Gadodiamide—Visual impairment—Temozolomide—melanoma	0.00409	0.0042	CcSEcCtD
Gadodiamide—Flushing—Carmustine—melanoma	0.00408	0.00419	CcSEcCtD
Gadodiamide—Ill-defined disorder—Bleomycin—melanoma	0.00406	0.00418	CcSEcCtD
Gadodiamide—Diarrhoea—Vemurafenib—melanoma	0.00404	0.00415	CcSEcCtD
Gadodiamide—Migraine—Docetaxel—melanoma	0.00402	0.00413	CcSEcCtD
Gadodiamide—Tinnitus—Temozolomide—melanoma	0.00396	0.00407	CcSEcCtD
Gadodiamide—Malaise—Bleomycin—melanoma	0.00395	0.00406	CcSEcCtD
Gadodiamide—Flushing—Temozolomide—melanoma	0.00394	0.00405	CcSEcCtD
Gadodiamide—Arrhythmia—Carmustine—melanoma	0.00392	0.00403	CcSEcCtD
Gadodiamide—Dizziness—Vemurafenib—melanoma	0.0039	0.00401	CcSEcCtD
Gadodiamide—Ataxia—Docetaxel—melanoma	0.00384	0.00394	CcSEcCtD
Gadodiamide—Chills—Temozolomide—melanoma	0.00381	0.00391	CcSEcCtD
Gadodiamide—Ill-defined disorder—Dactinomycin—melanoma	0.00379	0.0039	CcSEcCtD
Gadodiamide—Vomiting—Vemurafenib—melanoma	0.00375	0.00386	CcSEcCtD
Gadodiamide—Chest pain—Bleomycin—melanoma	0.00373	0.00383	CcSEcCtD
Gadodiamide—Myalgia—Bleomycin—melanoma	0.00373	0.00383	CcSEcCtD
Gadodiamide—Rash—Vemurafenib—melanoma	0.00372	0.00382	CcSEcCtD
Gadodiamide—Dermatitis—Vemurafenib—melanoma	0.00372	0.00382	CcSEcCtD
Gadodiamide—Headache—Vemurafenib—melanoma	0.0037	0.0038	CcSEcCtD
Gadodiamide—Discomfort—Bleomycin—melanoma	0.00368	0.00379	CcSEcCtD
Gadodiamide—Malaise—Dactinomycin—melanoma	0.00368	0.00379	CcSEcCtD
Gadodiamide—Dysgeusia—Temozolomide—melanoma	0.00362	0.00372	CcSEcCtD
Gadodiamide—Tremor—Carmustine—melanoma	0.00358	0.00368	CcSEcCtD
Gadodiamide—Anaphylactic shock—Bleomycin—melanoma	0.00357	0.00367	CcSEcCtD
Gadodiamide—Oedema—Bleomycin—melanoma	0.00357	0.00367	CcSEcCtD
Gadodiamide—Infection—Bleomycin—melanoma	0.00355	0.00365	CcSEcCtD
Gadodiamide—Nausea—Vemurafenib—melanoma	0.0035	0.0036	CcSEcCtD
Gadodiamide—Myalgia—Dactinomycin—melanoma	0.00348	0.00357	CcSEcCtD
Gadodiamide—Bronchospasm—Docetaxel—melanoma	0.00347	0.00356	CcSEcCtD
Gadodiamide—Tremor—Temozolomide—melanoma	0.00346	0.00356	CcSEcCtD
Gadodiamide—Discomfort—Dactinomycin—melanoma	0.00344	0.00353	CcSEcCtD
Gadodiamide—Ill-defined disorder—Temozolomide—melanoma	0.00343	0.00352	CcSEcCtD
Gadodiamide—Hypotension—Bleomycin—melanoma	0.00334	0.00343	CcSEcCtD
Gadodiamide—Oedema—Dactinomycin—melanoma	0.00333	0.00343	CcSEcCtD
Gadodiamide—Malaise—Temozolomide—melanoma	0.00333	0.00342	CcSEcCtD
Gadodiamide—Convulsion—Carmustine—melanoma	0.00331	0.0034	CcSEcCtD
Gadodiamide—Infection—Dactinomycin—melanoma	0.00331	0.0034	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Bleomycin—melanoma	0.00326	0.00335	CcSEcCtD
Gadodiamide—Chest pain—Carmustine—melanoma	0.00325	0.00335	CcSEcCtD
Gadodiamide—Myalgia—Carmustine—melanoma	0.00325	0.00335	CcSEcCtD
Gadodiamide—Anxiety—Carmustine—melanoma	0.00324	0.00333	CcSEcCtD
Gadodiamide—Paraesthesia—Bleomycin—melanoma	0.00321	0.0033	CcSEcCtD
Gadodiamide—Convulsion—Temozolomide—melanoma	0.0032	0.00329	CcSEcCtD
Gadodiamide—Dyspnoea—Bleomycin—melanoma	0.00319	0.00328	CcSEcCtD
Gadodiamide—Arthralgia—Temozolomide—melanoma	0.00314	0.00323	CcSEcCtD
Gadodiamide—Myalgia—Temozolomide—melanoma	0.00314	0.00323	CcSEcCtD
Gadodiamide—Anxiety—Temozolomide—melanoma	0.00313	0.00322	CcSEcCtD
Gadodiamide—Oedema—Carmustine—melanoma	0.00312	0.00321	CcSEcCtD
Gadodiamide—Discomfort—Temozolomide—melanoma	0.00311	0.00319	CcSEcCtD
Gadodiamide—Infection—Carmustine—melanoma	0.0031	0.00319	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Docetaxel—melanoma	0.0031	0.00319	CcSEcCtD
Gadodiamide—Renal failure—Docetaxel—melanoma	0.00309	0.00318	CcSEcCtD
Gadodiamide—Myocardial infarction—Docetaxel—melanoma	0.00308	0.00317	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Docetaxel—melanoma	0.00308	0.00317	CcSEcCtD
Gadodiamide—Dry mouth—Temozolomide—melanoma	0.00308	0.00316	CcSEcCtD
Gadodiamide—Pain—Bleomycin—melanoma	0.00306	0.00314	CcSEcCtD
Gadodiamide—Tachycardia—Carmustine—melanoma	0.00304	0.00313	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00304	0.00312	CcSEcCtD
Gadodiamide—Oedema—Temozolomide—melanoma	0.00301	0.0031	CcSEcCtD
Gadodiamide—Anaphylactic shock—Temozolomide—melanoma	0.00301	0.0031	CcSEcCtD
Gadodiamide—Infection—Temozolomide—melanoma	0.003	0.00308	CcSEcCtD
Gadodiamide—Nervous system disorder—Temozolomide—melanoma	0.00296	0.00304	CcSEcCtD
Gadodiamide—Feeling abnormal—Bleomycin—melanoma	0.00295	0.00303	CcSEcCtD
Gadodiamide—Hypotension—Carmustine—melanoma	0.00292	0.003	CcSEcCtD
Gadodiamide—Hyperhidrosis—Temozolomide—melanoma	0.00291	0.003	CcSEcCtD
Gadodiamide—Fatigue—Dactinomycin—melanoma	0.00287	0.00295	CcSEcCtD
Gadodiamide—Pain—Dactinomycin—melanoma	0.00285	0.00293	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Carmustine—melanoma	0.00284	0.00292	CcSEcCtD
Gadodiamide—Urticaria—Bleomycin—melanoma	0.00284	0.00292	CcSEcCtD
Gadodiamide—Rhinitis—Docetaxel—melanoma	0.00283	0.00291	CcSEcCtD
Gadodiamide—Body temperature increased—Bleomycin—melanoma	0.00283	0.0029	CcSEcCtD
Gadodiamide—Paraesthesia—Carmustine—melanoma	0.0028	0.00288	CcSEcCtD
Gadodiamide—Pharyngitis—Docetaxel—melanoma	0.0028	0.00288	CcSEcCtD
Gadodiamide—Urinary tract disorder—Docetaxel—melanoma	0.00279	0.00286	CcSEcCtD
Gadodiamide—Dyspnoea—Carmustine—melanoma	0.00278	0.00286	CcSEcCtD
Gadodiamide—Somnolence—Carmustine—melanoma	0.00277	0.00285	CcSEcCtD
Gadodiamide—Urethral disorder—Docetaxel—melanoma	0.00277	0.00284	CcSEcCtD
Gadodiamide—Feeling abnormal—Dactinomycin—melanoma	0.00275	0.00282	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Temozolomide—melanoma	0.00275	0.00282	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dactinomycin—melanoma	0.00273	0.0028	CcSEcCtD
Gadodiamide—Visual impairment—Docetaxel—melanoma	0.00272	0.0028	CcSEcCtD
Gadodiamide—Paraesthesia—Temozolomide—melanoma	0.00271	0.00278	CcSEcCtD
Gadodiamide—Dyspnoea—Temozolomide—melanoma	0.00269	0.00276	CcSEcCtD
Gadodiamide—Somnolence—Temozolomide—melanoma	0.00268	0.00275	CcSEcCtD
Gadodiamide—Pain—Carmustine—melanoma	0.00267	0.00274	CcSEcCtD
Gadodiamide—Dyspepsia—Temozolomide—melanoma	0.00265	0.00273	CcSEcCtD
Gadodiamide—Body temperature increased—Dactinomycin—melanoma	0.00263	0.00271	CcSEcCtD
Gadodiamide—Abdominal pain—Dactinomycin—melanoma	0.00263	0.00271	CcSEcCtD
Gadodiamide—Hypersensitivity—Bleomycin—melanoma	0.00263	0.00271	CcSEcCtD
Gadodiamide—Flushing—Docetaxel—melanoma	0.00262	0.00269	CcSEcCtD
Gadodiamide—Fatigue—Temozolomide—melanoma	0.0026	0.00267	CcSEcCtD
Gadodiamide—Pain—Temozolomide—melanoma	0.00258	0.00265	CcSEcCtD
Gadodiamide—Feeling abnormal—Carmustine—melanoma	0.00257	0.00264	CcSEcCtD
Gadodiamide—Asthenia—Bleomycin—melanoma	0.00256	0.00264	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Carmustine—melanoma	0.00255	0.00262	CcSEcCtD
Gadodiamide—Chills—Docetaxel—melanoma	0.00253	0.0026	CcSEcCtD
Gadodiamide—Pruritus—Bleomycin—melanoma	0.00253	0.0026	CcSEcCtD
Gadodiamide—Arrhythmia—Docetaxel—melanoma	0.00252	0.00259	CcSEcCtD
Gadodiamide—Feeling abnormal—Temozolomide—melanoma	0.00248	0.00255	CcSEcCtD
Gadodiamide—Body temperature increased—Carmustine—melanoma	0.00247	0.00253	CcSEcCtD
Gadodiamide—Abdominal pain—Carmustine—melanoma	0.00247	0.00253	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Temozolomide—melanoma	0.00247	0.00253	CcSEcCtD
Gadodiamide—Hypersensitivity—Dactinomycin—melanoma	0.00246	0.00252	CcSEcCtD
Gadodiamide—Dysgeusia—Docetaxel—melanoma	0.00241	0.00247	CcSEcCtD
Gadodiamide—Urticaria—Temozolomide—melanoma	0.0024	0.00246	CcSEcCtD
Gadodiamide—Asthenia—Dactinomycin—melanoma	0.00239	0.00246	CcSEcCtD
Gadodiamide—Abdominal pain—Temozolomide—melanoma	0.00238	0.00245	CcSEcCtD
Gadodiamide—Body temperature increased—Temozolomide—melanoma	0.00238	0.00245	CcSEcCtD
Gadodiamide—Hypersensitivity—Carmustine—melanoma	0.0023	0.00236	CcSEcCtD
Gadodiamide—Diarrhoea—Dactinomycin—melanoma	0.00228	0.00234	CcSEcCtD
Gadodiamide—Vomiting—Bleomycin—melanoma	0.00227	0.00234	CcSEcCtD
Gadodiamide—Rash—Bleomycin—melanoma	0.00225	0.00232	CcSEcCtD
Gadodiamide—Dermatitis—Bleomycin—melanoma	0.00225	0.00231	CcSEcCtD
Gadodiamide—Asthenia—Carmustine—melanoma	0.00224	0.0023	CcSEcCtD
Gadodiamide—Hypersensitivity—Temozolomide—melanoma	0.00222	0.00228	CcSEcCtD
Gadodiamide—Syncope—Docetaxel—melanoma	0.0022	0.00226	CcSEcCtD
Gadodiamide—Asthenia—Temozolomide—melanoma	0.00216	0.00222	CcSEcCtD
Gadodiamide—Loss of consciousness—Docetaxel—melanoma	0.00216	0.00222	CcSEcCtD
Gadodiamide—Diarrhoea—Carmustine—melanoma	0.00213	0.00219	CcSEcCtD
Gadodiamide—Pruritus—Temozolomide—melanoma	0.00213	0.00219	CcSEcCtD
Gadodiamide—Convulsion—Docetaxel—melanoma	0.00213	0.00219	CcSEcCtD
Gadodiamide—Nausea—Bleomycin—melanoma	0.00212	0.00218	CcSEcCtD
Gadodiamide—Vomiting—Dactinomycin—melanoma	0.00212	0.00218	CcSEcCtD
Gadodiamide—Rash—Dactinomycin—melanoma	0.0021	0.00216	CcSEcCtD
Gadodiamide—Arthralgia—Docetaxel—melanoma	0.00209	0.00215	CcSEcCtD
Gadodiamide—Chest pain—Docetaxel—melanoma	0.00209	0.00215	CcSEcCtD
Gadodiamide—Myalgia—Docetaxel—melanoma	0.00209	0.00215	CcSEcCtD
Gadodiamide—Dizziness—Carmustine—melanoma	0.00206	0.00212	CcSEcCtD
Gadodiamide—Diarrhoea—Temozolomide—melanoma	0.00206	0.00212	CcSEcCtD
Gadodiamide—Dry mouth—Docetaxel—melanoma	0.00205	0.0021	CcSEcCtD
Gadodiamide—Anaphylactic shock—Docetaxel—melanoma	0.002	0.00206	CcSEcCtD
Gadodiamide—Oedema—Docetaxel—melanoma	0.002	0.00206	CcSEcCtD
Gadodiamide—Dizziness—Temozolomide—melanoma	0.00199	0.00205	CcSEcCtD
Gadodiamide—Infection—Docetaxel—melanoma	0.00199	0.00205	CcSEcCtD
Gadodiamide—Vomiting—Carmustine—melanoma	0.00198	0.00204	CcSEcCtD
Gadodiamide—Nausea—Dactinomycin—melanoma	0.00198	0.00204	CcSEcCtD
Gadodiamide—Shock—Docetaxel—melanoma	0.00197	0.00203	CcSEcCtD
Gadodiamide—Rash—Carmustine—melanoma	0.00197	0.00202	CcSEcCtD
Gadodiamide—Nervous system disorder—Docetaxel—melanoma	0.00197	0.00202	CcSEcCtD
Gadodiamide—Dermatitis—Carmustine—melanoma	0.00197	0.00202	CcSEcCtD
Gadodiamide—Tachycardia—Docetaxel—melanoma	0.00196	0.00201	CcSEcCtD
Gadodiamide—Headache—Carmustine—melanoma	0.00195	0.00201	CcSEcCtD
Gadodiamide—Vomiting—Temozolomide—melanoma	0.00192	0.00197	CcSEcCtD
Gadodiamide—Rash—Temozolomide—melanoma	0.0019	0.00195	CcSEcCtD
Gadodiamide—Dermatitis—Temozolomide—melanoma	0.0019	0.00195	CcSEcCtD
Gadodiamide—Headache—Temozolomide—melanoma	0.00189	0.00194	CcSEcCtD
Gadodiamide—Hypotension—Docetaxel—melanoma	0.00187	0.00193	CcSEcCtD
Gadodiamide—Nausea—Carmustine—melanoma	0.00185	0.0019	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Docetaxel—melanoma	0.00183	0.00188	CcSEcCtD
Gadodiamide—Paraesthesia—Docetaxel—melanoma	0.0018	0.00185	CcSEcCtD
Gadodiamide—Nausea—Temozolomide—melanoma	0.00179	0.00184	CcSEcCtD
Gadodiamide—Dyspnoea—Docetaxel—melanoma	0.00179	0.00184	CcSEcCtD
Gadodiamide—Somnolence—Docetaxel—melanoma	0.00178	0.00183	CcSEcCtD
Gadodiamide—Dyspepsia—Docetaxel—melanoma	0.00176	0.00181	CcSEcCtD
Gadodiamide—Fatigue—Docetaxel—melanoma	0.00173	0.00178	CcSEcCtD
Gadodiamide—Pain—Docetaxel—melanoma	0.00171	0.00176	CcSEcCtD
Gadodiamide—Feeling abnormal—Docetaxel—melanoma	0.00165	0.0017	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Docetaxel—melanoma	0.00164	0.00169	CcSEcCtD
Gadodiamide—Body temperature increased—Docetaxel—melanoma	0.00158	0.00163	CcSEcCtD
Gadodiamide—Abdominal pain—Docetaxel—melanoma	0.00158	0.00163	CcSEcCtD
Gadodiamide—Hypersensitivity—Docetaxel—melanoma	0.00148	0.00152	CcSEcCtD
Gadodiamide—Asthenia—Docetaxel—melanoma	0.00144	0.00148	CcSEcCtD
Gadodiamide—Pruritus—Docetaxel—melanoma	0.00142	0.00146	CcSEcCtD
Gadodiamide—Diarrhoea—Docetaxel—melanoma	0.00137	0.00141	CcSEcCtD
Gadodiamide—Dizziness—Docetaxel—melanoma	0.00133	0.00136	CcSEcCtD
Gadodiamide—Vomiting—Docetaxel—melanoma	0.00127	0.00131	CcSEcCtD
Gadodiamide—Rash—Docetaxel—melanoma	0.00126	0.0013	CcSEcCtD
Gadodiamide—Dermatitis—Docetaxel—melanoma	0.00126	0.0013	CcSEcCtD
Gadodiamide—Headache—Docetaxel—melanoma	0.00126	0.00129	CcSEcCtD
Gadodiamide—Nausea—Docetaxel—melanoma	0.00119	0.00122	CcSEcCtD
